Low Dose Aspirin, COX-Inhibition and Chemoprevention of Colorectal Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|5|5|493-503

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.5, Iss.5, 2005-06, pp. : 493-503

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aspirin as a Chemoprevention Agent for Colorectal Cancer

By  

Current Drug Metabolism, Vol. 13, Iss. 9, 2012-11 ,pp. : 1313-1322

Bentham Science Publishers

Access to resources Recommend Favorite

Prevention of Cancer in the Upper Gastrointestinal Tract with COX-Inhibition. Still an Option?

By  

Current Pharmaceutical Design, Vol. 13, Iss. 22, 2007-08 ,pp. : 2261-2273

Bentham Science Publishers

Access to resources Recommend Favorite

Regular aspirin reduces COX-2-positive colorectal cancer risk

By  

Inpharma, Vol. 1, Iss. 1590, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

COX-2 and Colorectal Cancer

By  

Current Pharmaceutical Design, Vol. 9, Iss. 27, 2003-10 ,pp. : 2229-2251

Bentham Science Publishers

Access to resources Recommend Favorite

Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer

By Marin Jose J. G.   Sanchez de Medina Fermin   Castaño Beatriz   Bujanda Luis   Romero Marta R.   Martinez-Augustin Olga   Moral-Avila Rosario Del   Briz Oscar  

Drug Metabolism Reviews, Vol. 44, Iss. 2, 2012-05 ,pp. : 148-172

Informa Healthcare

Access to resources Recommend Favorite